Roles of NHERF1/EBP50 in cancer

被引：87

作者：

Georgescu, Maria-Magdalena ^{[1
]}

Morales, Fabiana C. ^{[1
]}

Molina, Jennifer R. ^{[1
]}

Hayashi, Yuho ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA

来源：

CURRENT MOLECULAR MEDICINE | 2008年 / 8卷 / 06期

关键词：

D O I：

10.2174/156652408785748031

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

This review summarizes the emerging roles of NHERF1/EBP50 adaptor protein in tumorigenesis. NHERF1/EBP50 ((N) under bara(+)/(H) under bar (+) (e) under bar xchanger (r) under bar egulating (f) under bar actor 1; ezrin-radixin-moesin ((E) under bar RM) (b) under bar inding (p) under bar hosphoprotein of 50 kDa) is a PDZ domain-containing protein with physiological localization at the plasma membrane. We discuss in this review the functions of NHERF1/EBP50 as a linker between membrane proteins and the cytoskeleton network, as well as its involvement in different types of cancer, such as breast and liver cancers. Recent evidence obtained from our laboratory and from other groups shows that NHERF1/EBP50 is an important player in cancer progression. It appears that, depending on its subcellular distribution, NHERF1/EBP50 may behave either as a tumor suppressor, when it is localized at the plasma membrane, or as an oncogenic protein, when it is shifted to the cytoplasm. We provide here an overview of the mechanisms by which this adaptor protein controls cell transformation, and propose a model suggesting a dual role of NHERF1/EBP50 in cancer.

引用

页码：459 / 468

页数：10

共 112 条

[41] PDZ domains: Folding and binding [J].

Jemth, Per ;

Gianni, Stefano .

BIOCHEMISTRY, 2007, 46 (30) :8701-8708

[42]

Kalikin LM, 1996, GENE CHROMOSOME CANC, V17, P64, DOI 10.1002/(SICI)1098-2264(199609)17:1<64::AID-GCC10>3.0.CO

[43]

2-H

[44] Crystal structure of the PDZ1 domain of human Na+/H+ exchanger regulatory factor provides insights into the mechanism of carboxyl-terminal leucine recognition by class IPDZ domains [J].

Karthikeyan, S ;

Leung, T ;

Birrane, G ;

Webster, G ;

Ladias, JAA .

JOURNAL OF MOLECULAR BIOLOGY, 2001, 308 (05) :963-973

[45] The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis [J].

Khanna C. ;

Wan X. ;

Bose S. ;

Cassaday R. ;

Olomu O. ;

Mendoza A. ;

Yeung C. ;

Gorlick R. ;

Hewitt S.M. ;

Helman L.J. .

Nature Medicine, 2004, 10 (2) :182-186

[46] Shifts in cellular localization of moesin in normal oral epithelium, oral epithelial dysplasia, verrucous carcinoma and oral squamous cell carcinoma [J].

Kobayashi, H ;

Sagara, J ;

Masumoto, J ;

Kurita, H ;

Kurashina, K ;

Taniguchi, S .

JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2003, 32 (06) :344-349

[47] Cortical stabilization of β-catenin contributes to NHERF1/EBP50 tumor suppressor function [J].

Kreimann, E. L. ;

Morales, F. C. ;

de Orbeta-Cruz, J. ;

Takahashi, Y. ;

Adams, H. ;

Liu, T-J ;

McCrea, P. D. ;

Georgescu, M-M .

ONCOGENE, 2007, 26 (36) :5290-5299

[48] The emerging role of PDZ adapter proteins for regulation of intestinal ion transport [J].

Lamprecht, G. ;

Seidler, U. .

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 291 (05) :G766-G777

[49] Oligomerization of NHERF-1 and NHERF-2 PDZ domains: Differential regulation by association with receptor carboxyl-termini and by phosphorylation [J].

Lau, AG ;

Hall, RA .

BIOCHEMISTRY, 2001, 40 (29) :8572-8580

[50] The Na+/H+ exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface [J].

Lazar, CS ;

Cresson, CM ;

Lauffenburger, DA ;

Gill, GN .

MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (12) :5470-5480

← 1 2 3 4 5 6 7 8 9 10 →